Prostatype Genomics AB (OSTO:PROGEN) EV-to-Revenue : 58.54 (As of Jun. 03, 2025)

Prostatype Genomics AB EV-to-Revenue Chart

Prostatype Genomics AB Semi-Annual Data
	Jun18	Jun19	Jun20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EV-to-Revenue	Get a 7-Day Free Trial						55.46	38.97	19.59	-	326.98

Competitive Comparison of Prostatype Genomics AB's EV-to-Revenue

For the Diagnostics & Research subindustry, Prostatype Genomics AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Prostatype Genomics AB's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prostatype Genomics AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Prostatype Genomics AB's EV-to-Revenue falls into.

Prostatype Genomics AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Prostatype Genomics AB's EV-to-Revenue for today is calculated as:

Prostatype Genomics AB's current Enterprise Value is kr11.65 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Prostatype Genomics AB's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prostatype Genomics AB  (OSTO:PROGEN) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Prostatype Genomics AB's PS Ratiofor today is calculated as:

Prostatype Genomics AB's share price for today is kr1.665.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was kr0.06.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Prostatype Genomics AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Prostatype Genomics AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Prostatype Genomics AB Business Description